Testosterone Dodecanoate Compositions and Methods

Abstract: disclosed is a method and oral composition for treating a plurality of end stage diseases such as end-stage renal disease, chronic kidney disease, liver cirrhosis, chronic liver failure, end stage liver disease, cancer, congestive heart failure, pulmonary fibrosis, chronic obstructive pulmonary disease. in an embodiment of the invention, the composition comprises testosterone duodecanoate.

Inventor(s): Mahesh V. Patel, Kongnara Papangkorn, Jonathan Ogle, Nachiappan Chidambaram, Benjamin J. Bruno

CPC Classification: A61K31/568 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250195539